However, our ultimate aim is to include predictions of the outcome in patients with malaria using a disease‐specific virtual population incorporating physiological differences observed in patients with malaria, such as reduced CYP3A4 expression and changes in blood binding. This evidence concerns the gene CYP3A4 and malaria.